Private Equity

Updated:

The New Normal Fund

The New Normal Fund invests in early-stage companies building infrastructure for distributed work, digital health, and borderless finance from San...

The New Normal Fund logo

The New Normal Fund

The New Normal Fund launched in San Francisco to invest behind durable shifts in how people work, access care, and manage money — shifts accelerated by but not dependent on the pandemic period. The firm's founding thesis holds that distributed workforces, telemedicine adoption, and digital-first financial services represent structural resets, not cyclical trends. While the precise founding year and named principals remain undisclosed in public filings, the fund's activity indicates a manager operating at the intersection of venture capital and thematic conviction. Strategy concentrates on early-stage venture, spanning seed through pre-IPO, with a portfolio built around platforms that unbundle geographic constraints from economic participation. The firm has deployed into enterprise collaboration infrastructure, telehealth enablement layers, and fintech APIs that serve globally distributed users. Confirmed investments follow a pattern of backing technical founders building coordination software, regulatory-compliant health delivery stacks, and cross-border payment orchestration — though specific portfolio company names are not publicly cataloged at this time. Geographic focus covers North American-founded companies with inherently global user bases from first product launch. The fund's scale remains opaque — no AUM, deployment total, or team headcount is publicly reported. No LinkedIn presence for the firm or its principals is documented, and no regulatory filings have surfaced to independently verify fund size. Without disclosed adjacent vehicles, philanthropic arms, or co-investor networks, the operating structure appears deliberately lean. No verifiable personnel moves, fund closes, or operational events in the last 24 months have been recorded in financial press. Structural differentiation lies in the fund's name itself — 'The New Normal' is a thesis-as-brand, signaling to founders and limited partners that every investment maps to a specific worldview about permanently altered societal infrastructure. This is not a generalist seed fund adding remote-work as one of twelve themes; it appears to be a single-thesis vehicle where the investment committee's mandate is definitionally constrained. The governance and succession architecture remains private, but the architectural choice to embed the thesis in the firm's public identity imposes a discipline that diversified venture platforms rarely replicate.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

San Francisco

Corporate office

San Francisco, CA, United States

Sector focus

Enterprise SoftwareFuture of WorkDigital HealthFinTech

Frequently asked questions

What investment stages does The New Normal Fund target?

The firm deploys across early-stage venture, spanning seed, start-up, and expansion through pre-IPO rounds, per its stated strategy. This provides flexibility to support companies from initial product development through growth-stage scaling, though the firm's precise check sizes and reserve strategy are not publicly disclosed.

What is the investment thesis behind 'The New Normal'?

The fund invests exclusively in companies that enable and benefit from permanently distributed living, working, and service delivery. This encompasses enterprise collaboration platforms, telehealth infrastructure, and fintech tools designed for users unmoored from any single geography — sectors the firm views as structurally reset rather than temporarily accelerated.

Does The New Normal Fund participate in fund commitments or only direct deals?

The firm's disclosed strategy focuses on direct venture investments, and there is no public evidence of fund-of-funds commitments or SPV participation alongside external GPs. The operational model appears oriented toward direct equity positions in portfolio companies.

Who runs investment decisions at The New Normal Fund?

The firm has not publicly disclosed its named principals, investment committee members, or key decision-makers. No biographies or team pages are available, and no media profiles have identified the individuals responsible for capital allocation.

Which sectors does The New Normal Fund explicitly avoid?

Based on the firm's thesis-concentrated posture, sectors outside the distributed-work, digital health, and fintech infrastructure thesis — such as hardtech, industrial manufacturing, or traditional brick-and-mortar retail — appear excluded by mandate. No published sector-exclusion list exists, but the brand-as-thesis model implies a narrow aperture.

Is The New Normal Fund structured as a single fund or a series of vehicles?

Public records do not confirm whether the firm operates a single fund vehicle or a series of vintages. No Form D filings, fund closes, or SEC registrations have been independently verified to map the legal structure of the investment vehicles.

Does The New Normal Fund maintain philanthropic structures or impact allocations?

No philanthropic foundations, donor-advised funds, or impact investing sidecars are publicly associated with the firm or any named principal. The entity's external profile is limited to its venture investment activity.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More San Francisco Private Equity profiles